← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT06138236

NCT06138236 Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06138236
Status Recruiting
Phase EARLY_Phase 1
Sponsor Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Condition Plantar Fascitis
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2023-07-01
Primary Completion 2025-12-31

Trial Parameters

Condition Plantar Fascitis
Sponsor Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 84
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2023-07-01
Completion 2025-12-31
Interventions
Collagen hydrolyzed peptides

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Eligibility Criteria

Inclusion Criteria: Plantar fascitiis Aged between 18 and 80 years old Exclusion Criteria: * Previous surgery of the foot * Contraindications to ESWT

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE PLANTAR FASCITIS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology